Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2015

Nov 9, 2015

29745_dirs_2015-11-09_10bacc6a-bc83-4bde-b13b-8f3c674bd243.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2015-11-05

Reporting Person: Ricks David A (SVP and Pres, Lilly Bio-Meds)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-11-05 Common Stock M 4970 $56.18 Acquired 65108 Direct
2015-11-05 Common Stock F 3924 $81.05 Disposed 61184 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-11-05 Employee stock option 2/06 (right to buy) $56.18 M 4970 Disposed 2016-02-09 Common Stock (4970.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4024 Indirect